The substantial rise in Vivos Therapeutics' stock price triggered a circuit breaker, which is designed to prevent excessive volatility. This halt could attract more attention to the stock, potentially leading to increased demand once trading resumes. However, such a sharp increase could also lead to profit-taking, resulting in short-term volatility when the halt is lifted.